Screening for lung cancer using thin‐slice low‐dose computed tomography in southwestern China: a population‐based real‐world study

Abstract

AbstractObjectivesLung cancer is one of the most common malignant tumors threatening human life and health. At present, low‐dose computed tomography (LDCT) screening for the high‐risk population to achieve early diagnosis and treatment of lung cancer has become the first choice recommended by many authoritative international medical organizations. To further optimize the lung cancer screening method, we conducted a real‐world study of LDCT lung cancer screening in a large sample of a healthy physical examination population, comparing differences in lung nodules and lung cancer detection between thin and thick‐slice LDCT scanning.MethodsA total of 29 296 subjects who underwent low‐dose thick‐slice CT scanning (5 mm thickness) from January 2015 to December 2015 and 28 058 subjects who underwent low‐dose thin‐slice CT scanning (1 mm thickness) from January 2018 to December 2018 in West China Hospital were included. The positive detection rate, detection rate of lung cancer, pathological stage of lung cancer, and mortality rate of lung cancer were analyzed and compared between the two groups.ResultsThe positive rate of LDCT screening in the thin‐slice scanning group was significantly higher than that in the thick‐slice scanning group (20.1% vs. 14.4%, p < 0.001). In addition, the lung cancer detection rate in the thin‐slice LDCT screening positive group was significantly higher than that in the thick‐slice scanning group (78.0% vs. 52.9%, p < 0.001).ConclusionsThe screening positive rate of low‐dose thin‐slice CT scanning is higher and more early‐stage lung cancer (IA1 stage) can be detected in the screen‐positive group.